Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Beilstein journal of nanotechnology, 10.2019, S. 1707-1715
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2019
- Creator
-
Onafuye, Hannah
Pieper, Sebastian
Mulac, Dennis
Cinatl, Jindrich
Wass, Mark N.
Langer, Klaus
Michaelis, Martin
- DOI
-
10.3762/bjnano.10.166
- URN
-
urn:nbn:de:hebis:30:3-733486
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Onafuye, Hannah
- Pieper, Sebastian
- Mulac, Dennis
- Cinatl, Jindrich
- Wass, Mark N.
- Langer, Klaus
- Michaelis, Martin
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2019
Other Objects (12)
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Impact of the COVID-19 pandemic on the circulation of other pathogens in England
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
COVID-19-related coagulopathy - is transferrin a missing link?
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
The story of human cytomegalovirus and cancer: increasing evidence and open questions
Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza A virus activity exerted by baicalein and biochanin A
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Impact of the COVID-19 pandemic on the circulation of other pathogens in England
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
COVID-19-related coagulopathy - is transferrin a missing link?
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
The story of human cytomegalovirus and cancer: increasing evidence and open questions
Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza A virus activity exerted by baicalein and biochanin A
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Impact of the COVID-19 pandemic on the circulation of other pathogens in England
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
COVID-19-related coagulopathy - is transferrin a missing link?
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
The story of human cytomegalovirus and cancer: increasing evidence and open questions